TY - JOUR T1 - Age-specific effects of childhood Body Mass Index on multiple sclerosis risk JF - medRxiv DO - 10.1101/2021.09.12.21263445 SP - 2021.09.12.21263445 AU - Luke Hone AU - Benjamin M Jacobs AU - Charles Marshall AU - Gavin Giovannoni AU - Alastair Noyce AU - Ruth Dobson Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/11/08/2021.09.12.21263445.abstract N2 - Objective Higher Body Mass Index (BMI) during early life is thought to be a causal risk factor for Multiple Sclerosis (MS). We used longitudinal mendelian randomisation (MR) to determine whether there is a critical window during which BMI influences MS risk.Methods Summary statistics for childhood BMI and for MS susceptibility were obtained from recent large GWAS. We generated exposure instruments for BMI during four non-overlapping epochs (< 3 months, 3 months-1.5 years, 2-5 years, and 7-8 years) and performed MR using the inverse-variance weighted method with standard sensitivity analyses. Multivariable MR was used to account for effects mediated via later-life BMI.Results For all time epochs other than birth, genetically determined higher BMI was associated with an increased liability to MS: Birth (OR 0.81, 95% CI 0.50-1.31, NSNPs=7, p=0.39), Infancy (OR 1.18, 95%CI 1.04-1.33, NSNPs=18, p=0.01), Early childhood (OR 1.31, 95%CI 1.03-1.66, NSNPs=4, p=0.03), Later childhood (OR 1.34, 95% CI 1.08-1.66, NSNPs=4, p=0.01). Multivariable MR suggested that these effects may be mediated by effects on adult BMI.Conclusion We provide evidence using MR that genetically-determined higher BMI during early life is associated with increased MS risk. This effect may be driven by shared genetic architecture with later-life BMI.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was performed at the Preventive Neurology Unit, which is funded by the Barts Charity. BMJ is supported by an MRC Clinical Research Training Fellowship.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was performed using publicly available data sources. There were no experiments performed on human subjects and no direct patient contact, therefore written consent was not required.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesWe thank MoBa, Prof Stefan Johansson and Marc Vaudel for providing summary statistics for childhood BMI. We thank the IMSGC for providing MS GWAS data. We thank MR-Base for making the TwoSampleMR package available publicly. Download links for datasets used in this study are provided above. All code used in this study is available at https://github.com/benjacobs123456/MR_MOBA_MS. https://github.com/benjacobs123456/MR_MOBA_MS https://egg-consortium.org https://imsgc.net/ https://portals.broadinstitute.org/collaboration/giant/index.php/GIANT_consortium_data_files ER -